Evidence map›Paper›PMID 42073445›Full record

ArticleLife (Basel, Switzerland)2026

Impact of PD-L1 Status on the Development of Cutaneous Immune-Related Adverse Events in Non-Small-Cell Lung Cancer Patients Receiving Immunotherapy.

Alexander Yakobson, Fahed Abu Salamah, Ibrahim Alatawneh, Ahron Yehonatan Cohen, Yuliya Valdman-Grinshpoun, Yotam Malek, Itamar Gothelf, Ashraf Abu Jama, Nashat Abu Yasin, Mhammad Abu Juda and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alexander YakobsonThe Legacy Heritage Center and Dr Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.
Fahed Abu SalamahFaculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Ibrahim AlatawnehFaculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Ahron Yehonatan CohenThe Legacy Heritage Center and Dr Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.
Yuliya Valdman-GrinshpounFaculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Yotam MalekFaculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Itamar GothelfGoldman Medical School, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Ashraf Abu JamaThe Legacy Heritage Center and Dr Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.
Nashat Abu YasinThe Legacy Heritage Center and Dr Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.
Mhammad Abu JudaThe Legacy Heritage Center and Dr Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.
Arina SoklakovaFaculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Amichay MeirovitzThe Legacy Heritage Center and Dr Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.
Walid ShalataThe Legacy Heritage Center and Dr Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.ORCID 0000-0002-7570-4550

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immune checkpoint inhibitorsimmunotherapynon-small-cell lung canceroverall survivalprogrammed cell death protein 1progression-free survivalreal-world data

Identifiers

PMID42073445
PMCPMC13117193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.